Clostridium, Bacteroides and Prevotella associates with increased fecal metabolites Trans-4-Hydroxy-L-proline and Genistein in active pulmonary tuberculosis patients during anti-tuberculosis chemotherapy with isoniazid-rifampin-pyrazinamide-ethambutol (HRZE)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
0973-7715
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clostridium, Bacteroides and Prevotella associates with increased fecal metabolites Trans-4-Hydroxy-L-proline and Genistein in active pulmonary tuberculosis patients during anti-tuberculosis chemotherapy with isoniazid-rifampin-pyrazinamide-ethambutol (HRZE) ; day:24 ; month:3 ; year:2022 ; pages:1-10
Indian journal of microbiology ; (24.3.2022), 1-10
- Creator
-
Meng, Ruijie
Dong, Wenya
Gao, Jie
Lu, Chunrong
Zhang, Chenchen
Liao, Qinghua
Chen, Liang
Wu, Huizhong
Hu, Jiwen
Wei, Wenjing
Jiang, Zhenyou
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12088-022-01003-2
- URN
-
urn:nbn:de:101:1-2022061519380954676161
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Meng, Ruijie
- Dong, Wenya
- Gao, Jie
- Lu, Chunrong
- Zhang, Chenchen
- Liao, Qinghua
- Chen, Liang
- Wu, Huizhong
- Hu, Jiwen
- Wei, Wenjing
- Jiang, Zhenyou
- SpringerLink (Online service)
Other Objects (12)
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
Treatment of isoniazid-resistant pulmonary tuberculosis
Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
Mycobacterium tuberculosis lineages and anti-tuberculosis drug resistance in reference hospitals across Viet Nam
Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
First identification of marine diatoms with anti-tuberculosis activity
Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia
Clinical outcomes of multidrug-resistant tracheobronchial tuberculosis receiving anti-tuberculosis regimens containing bedaquiline or delamanid
A metabolic biosignature of early response to anti-tuberculosis treatment
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
Treatment of isoniazid-resistant pulmonary tuberculosis
Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
Mycobacterium tuberculosis lineages and anti-tuberculosis drug resistance in reference hospitals across Viet Nam
Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
First identification of marine diatoms with anti-tuberculosis activity
Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia
Clinical outcomes of multidrug-resistant tracheobronchial tuberculosis receiving anti-tuberculosis regimens containing bedaquiline or delamanid
A metabolic biosignature of early response to anti-tuberculosis treatment
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
Treatment of isoniazid-resistant pulmonary tuberculosis
Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
Mycobacterium tuberculosis lineages and anti-tuberculosis drug resistance in reference hospitals across Viet Nam
Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
First identification of marine diatoms with anti-tuberculosis activity
Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia
Clinical outcomes of multidrug-resistant tracheobronchial tuberculosis receiving anti-tuberculosis regimens containing bedaquiline or delamanid
A metabolic biosignature of early response to anti-tuberculosis treatment
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance